OptimMRI (v2) is an AI-enabled medical device from Rebrain, SAS, listed by FDA (510(k), K242054) with a decision date of 2024-08-12. Review panel: Radiology.
| FDA submission number | K242054 |
|---|---|
| Pathway | 510(k) |
| Company | Rebrain, SAS |
| Review panel (specialty) | Radiology |
| FDA decision date | 2024-08-12 |
| Decision | Substantially Equivalent |
| Product code | QIH |
| Classification | Automated Radiological Image Processing Software |
| Device class | 2 |
| Regulation number | 892.2050 |
| Review time (calendar days) | 28 |
| Applicant country | FR |
Official FDA database record · FDA AI-enabled device list
All Radiology AI devices · Full device index
Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.